These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 25891142)

  • 1. Antimalarial drug resistance in Africa: key lessons for the future.
    Takala-Harrison S; Laufer MK
    Ann N Y Acad Sci; 2015 Apr; 1342():62-7. PubMed ID: 25891142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Combined antimalarial therapy using artemisinin].
    Majori G
    Parassitologia; 2004 Jun; 46(1-2):85-7. PubMed ID: 15305693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of chloroquine, amodiaquine, sulfadoxine-pyrimethamine, chloroquine-sulfadoxine-pyrimethamine combination, and amodiaquine-sulfadoxine-pyrimethamine combination in Central African children with noncomplicated malaria.
    Menard D; Madji N; Manirakiza A; Djalle D; Koula MR; Talarmin A
    Am J Trop Med Hyg; 2005 May; 72(5):581-5. PubMed ID: 15940847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Artemisinin versus nonartemisinin combination therapy for uncomplicated malaria: randomized clinical trials from four sites in Uganda.
    Yeka A; Banek K; Bakyaita N; Staedke SG; Kamya MR; Talisuna A; Kironde F; Nsobya SL; Kilian A; Slater M; Reingold A; Rosenthal PJ; Wabwire-Mangen F; Dorsey G
    PLoS Med; 2005 Jul; 2(7):e190. PubMed ID: 16033307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative efficacy of antimalarial drugs including ACTs in the treatment of uncomplicated malaria among children under 5 years in Ghana.
    Koram KA; Abuaku B; Duah N; Quashie N
    Acta Trop; 2005 Sep; 95(3):194-203. PubMed ID: 16054584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amodiaquine alone, amodiaquine+sulfadoxine-pyrimethamine, amodiaquine+artesunate, and artemether-lumefantrine for outpatient treatment of malaria in Tanzanian children: a four-arm randomised effectiveness trial.
    Mutabingwa TK; Anthony D; Heller A; Hallett R; Ahmed J; Drakeley C; Greenwood BM; Whitty CJ
    Lancet; 2005 Apr 23-29; 365(9469):1474-80. PubMed ID: 15850631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular monitoring of Plasmodium falciparum resistance to antimalarial drugs after adoption of sulfadoxine-pyrimethamine plus artesunate as the first line treatment in Iran.
    Afsharpad M; Zakeri S; Pirahmadi S; Djadid ND
    Acta Trop; 2012 Jan; 121(1):13-8. PubMed ID: 22001304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination treatments for uncomplicated falciparum malaria in Kampala, Uganda: randomised clinical trial.
    Staedke SG; Mpimbaza A; Kamya MR; Nzarubara BK; Dorsey G; Rosenthal PJ
    Lancet; 2004 Nov 27-Dec 3; 364(9449):1950-7. PubMed ID: 15567011
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intermittent screening and treatment or intermittent preventive treatment with dihydroartemisinin-piperaquine versus intermittent preventive treatment with sulfadoxine-pyrimethamine for the control of malaria during pregnancy in western Kenya: an open-label, three-group, randomised controlled superiority trial.
    Desai M; Gutman J; L'lanziva A; Otieno K; Juma E; Kariuki S; Ouma P; Were V; Laserson K; Katana A; Williamson J; ter Kuile FO
    Lancet; 2015 Dec; 386(10012):2507-19. PubMed ID: 26429700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chloroquine resistant Plasmodium falciparum malaria in Osogbo Nigeria: efficacy of amodiaquine + sulfadoxine-pyrimethamine and chloroquine + chlorpheniramine for treatment.
    Ogungbamigbe TO; Ojurongbe O; Ogunro PS; Okanlawon BM; Kolawole SO
    Mem Inst Oswaldo Cruz; 2008 Feb; 103(1):79-84. PubMed ID: 18368238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evolution of Plasmodium falciparum drug resistance: implications for the development and containment of artemisinin resistance.
    Mita T; Tanabe K
    Jpn J Infect Dis; 2012; 65(6):465-75. PubMed ID: 23183197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fighting fire with fire: mass antimalarial drug administrations in an era of antimalarial resistance.
    von Seidlein L; Dondorp A
    Expert Rev Anti Infect Ther; 2015 Jun; 13(6):715-30. PubMed ID: 25831482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rationale and prospects of combination therapy as a strategy for delaying antimalarial drug resistance.
    Alexander ND
    P N G Med J; 2001; 44(1-2):1-5. PubMed ID: 12418672
    [No Abstract]   [Full Text] [Related]  

  • 14. Prevention of increasing rates of treatment failure by combining sulfadoxine-pyrimethamine with artesunate or amodiaquine for the sequential treatment of malaria.
    Dorsey G; Vlahos J; Kamya MR; Staedke SG; Rosenthal PJ
    J Infect Dis; 2003 Oct; 188(8):1231-8. PubMed ID: 14551894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adding artesunate to sulphadoxine-pyrimethamine greatly improves the treatment efficacy in children with uncomplicated falciparum malaria on the coast of Benin, West Africa.
    Nahum A; Erhart A; Gazard D; Agbowai C; Van Overmeir C; van Loen H; Menten J; Akogbeto M; Coosemans M; Massougbodji A; D'Alessandro U
    Malar J; 2007 Dec; 6():170. PubMed ID: 18154655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antimalarial efficacy of chloroquine, amodiaquine, sulfadoxine-pyrimethamine, and the combinations of amodiaquine + artesunate and sulfadoxine-pyrimethamine + artesunate in Huambo and Bie provinces, central Angola.
    Guthmann JP; Ampuero J; Fortes F; van Overmeir C; Gaboulaud V; Tobback S; Dunand J; Saraiva N; Gillet P; Franco J; Denoncin A; van Herp M; Balkan S; Dujardin JC; D'Alessandro U; Legros D
    Trans R Soc Trop Med Hyg; 2005 Jul; 99(7):485-92. PubMed ID: 15876443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Withdrawing antimalarial drugs: impact on parasite resistance and implications for malaria treatment policies.
    Laufer MK; Plowe CV
    Drug Resist Updat; 2004; 7(4-5):279-88. PubMed ID: 15533765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemotherapy of malaria and resistance to antimalarial drugs in Guayana area, Venezuela.
    Caraballo A; Rodriguez-Acosta A
    Am J Trop Med Hyg; 1999 Jul; 61(1):120-4. PubMed ID: 10432068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antimalarial compounds: from bench to bedside.
    Olliaro PL; Taylor WR
    J Exp Biol; 2003 Nov; 206(Pt 21):3753-9. PubMed ID: 14506210
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized comparison of chloroquine plus sulfadoxine-pyrimethamine versus artesunate plus mefloquine versus artemether-lumefantrine in the treatment of uncomplicated falciparum malaria in the Lao People's Democratic Republic.
    Mayxay M; Khanthavong M; Lindegårdh N; Keola S; Barends M; Pongvongsa T; Yapom R; Annerberg A; Phompida S; Phetsouvanh R; White NJ; Newton PN
    Clin Infect Dis; 2004 Oct; 39(8):1139-47. PubMed ID: 15486837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.